Studies related to Risk of Alzheimer’s Disease and Vitamin E

Vitamin E And Donepezil For The Treatment Of Mild Cognitive Impairment

Effect None
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 769
Sex Both Genders
Age Range 65+
Notes for this study:
In older persons with cognitive decline, many of whom developed Alzheimer's disease over the course of the trial, Vitamin E supplementation (2,000 IU daily) failed to exert any significant protective effect relative to placebo.